Evolution and emergence of primate-specific interferon regulatory factor 9.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
02 2023
Historique:
revised: 18 01 2023
received: 26 12 2022
accepted: 19 01 2023
pubmed: 25 1 2023
medline: 3 3 2023
entrez: 24 1 2023
Statut: ppublish

Résumé

The binding of interferon (IFN) to its receptors leads to formation of IFN-stimulated gene factor 3 (ISGF3) complex that activates the transcription of cellular IFN-regulated genes. IFN regulatory factor 9 (IRF9, also called ISGF3γ or p48) is a key component of ISGF3. However, there is limited knowledge regarding the molecular evolution of IRF9 among vertebrates. In this study, we have identified the existence of the IRF9 gene in cartilaginous fish (sharks). Among primates, several isoforms unique to old world moneys and great apes are identified. These IRF9 isoforms are named as primate-specific IRF9 (PS-IRF9) to distinguish from canonical IRF9. PS-IRF9 originates from a unique exon usage and differential splicing in the IRF9 gene. Although the N-terminus are identical for all IRF9s, the C-terminal regions of the PS-IRF9 are completely different from canonical IRF9. In humans, two PS-IRF9s are identified and their RNA transcripts were detected in human primary peripheral blood mononuclear cells. In addition, human PS-IRF9 proteins were detected in human cell lines. Sharing the N-terminal exons with the canonical IRF9 proteins, PS-IRF9 is predicted to bind to the same DNA sequences as the canonical IRF9 proteins. As the C-terminal regions of IRFs are the determinants of IRF functions, PS-IRF9 may offer unique biological functions and represent a novel signaling molecule involved in the regulation of the IFN pathway in a primate-specific manner.

Identifiants

pubmed: 36691924
doi: 10.1002/jmv.28521
pmc: PMC10107944
doi:

Substances chimiques

Interferon-Stimulated Gene Factor 3, gamma Subunit 0
Protein Isoforms 0
IRF9 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e28521

Informations de copyright

© 2023 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.

Références

Dev Comp Immunol. 2018 Apr;81:324-333
pubmed: 29253557
Proc Natl Acad Sci U S A. 1990 Nov;87(21):8555-9
pubmed: 2236065
Mol Cell Biol. 1996 Dec;16(12):6957-64
pubmed: 8943351
Cancer Res. 2001 Sep 1;61(17):6540-7
pubmed: 11522652
J Virol. 2017 Oct 27;91(22):
pubmed: 28878077
Fish Shellfish Immunol. 2018 Feb;73:145-151
pubmed: 29246809
Front Immunol. 2017 Mar 02;8:209
pubmed: 28303139
Int J Cancer. 2015 Feb 15;136(4):E51-61
pubmed: 25156627
Immunity. 2012 Apr 20;36(4):503-14
pubmed: 22520844
Science. 1994 Jun 3;264(5164):1415-21
pubmed: 8197455
Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E601-E609
pubmed: 29317535
Nat Rev Immunol. 2014 Jan;14(1):36-49
pubmed: 24362405
J Med Virol. 2023 Feb;95(2):e28521
pubmed: 36691924
Nature. 2005 Apr 7;434(7034):772-7
pubmed: 15800576
J Interferon Cytokine Res. 2002 Jan;22(1):95-101
pubmed: 11846980
BMC Immunol. 2010 May 05;11:22
pubmed: 20444275
Clin Microbiol Rev. 2001 Oct;14(4):778-809, table of contents
pubmed: 11585785
J Autoimmun. 2017 May;79:105-111
pubmed: 28318807
Nature. 2003 Jan 23;421(6921):409-12
pubmed: 12540910
Dev Comp Immunol. 2010 Aug;34(8):855-65
pubmed: 20363250
Am J Primatol. 2000 Mar;50(3):169-85
pubmed: 10711532
J Biol Chem. 1997 Aug 8;272(32):20070-6
pubmed: 9242679
Front Immunol. 2018 Aug 10;9:1831
pubmed: 30147694
Nucleic Acids Res. 2021 Jul 2;49(W1):W293-W296
pubmed: 33885785
Annu Rev Anim Biosci. 2014 Feb;2:41-63
pubmed: 25384134
Immunity. 2006 Sep;25(3):349-60
pubmed: 16979567
Annu Rev Immunol. 2008;26:535-84
pubmed: 18303999
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
Sci Rep. 2020 Mar 11;10(1):4508
pubmed: 32161340
Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7227-32
pubmed: 9207073
Mol Phylogenet Evol. 1999 Nov;13(2):348-59
pubmed: 10603263
Semin Cancer Biol. 2001 Dec;11(6):445-53
pubmed: 11669606
Oncotarget. 2016 Aug 23;7(34):55377-55394
pubmed: 27421136
Protein Sci. 2004 May;13(5):1422-5
pubmed: 15075401
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):3906-3911
pubmed: 29581268
Mol Cell Biol. 1993 Jan;13(1):196-206
pubmed: 8417326
Annu Rev Microbiol. 2001;55:255-81
pubmed: 11544356
Evolution. 2003 Nov;57(11):2636-43
pubmed: 14686538
Mol Biol Evol. 2009 Nov;26(11):2539-50
pubmed: 19638535
Hypertension. 2014 Jan;63(1):119-27
pubmed: 24144649

Auteurs

Sam Drury (S)

School of Biological Sciences, University of Nebraska, Lincoln, Nebraska, USA.

Grace Claussen (G)

School of Biological Sciences, University of Nebraska, Lincoln, Nebraska, USA.

Allison Zetterman (A)

School of Biological Sciences, University of Nebraska, Lincoln, Nebraska, USA.

Hideaki Moriyama (H)

School of Biological Sciences, University of Nebraska, Lincoln, Nebraska, USA.

Etsuko N Moriyama (EN)

School of Biological Sciences, University of Nebraska, Lincoln, Nebraska, USA.
Center for Plant Science Innovation, University of Nebraska, Lincoln, Nebraska, USA.

Luwen Zhang (L)

School of Biological Sciences, University of Nebraska, Lincoln, Nebraska, USA.
Nebraska Center for Virology, University of Nebraska, Lincoln, Nebraska, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH